Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Class A Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
65M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
41.1M
-
Shares change
-
+5.85M
-
Total reported value, excl. options
-
$178M
-
Value change
-
+$26.9M
-
Put/Call ratio
-
2.48
-
Number of buys
-
32
-
Number of sells
-
-36
-
Price
-
$4.33
Significant Holders of Zura Bio Ltd - Class A Ordinary Shares, $0.0001 par value (ZURA) as of Q3 2025
84 filings reported holding ZURA - Zura Bio Ltd - Class A Ordinary Shares, $0.0001 par value as of Q3 2025.
Zura Bio Ltd - Class A Ordinary Shares, $0.0001 par value (ZURA) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.1M shares
of 65M outstanding shares and own 63.26% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (5.47M shares), VR ADVISER, LLC (4.63M shares), JPMORGAN CHASE & CO (4.62M shares), GREAT POINT PARTNERS LLC (3.82M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.05M shares), Pfizer Inc (2.97M shares), BRAIDWELL LP (2.47M shares), Ikarian Capital, LLC (2.13M shares), ARMISTICE CAPITAL, LLC (1.56M shares), and Affinity Asset Advisors, LLC (1.27M shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.